<DOC>
	<DOCNO>NCT00098033</DOCNO>
	<brief_summary>The goal objective project evaluate antileukemic activity investigational agent clofarabine patient acute myelogenous leukemia ( AML ) , acute lymphocytic leukemia ( ALL ) , chronic myelogenous leukemia ( CML ) accelerate blastic phase .</brief_summary>
	<brief_title>Investigation Clofarabine Acute Leukemias</brief_title>
	<detailed_description>The specific aim project ( 1 ) conduct phase II study clofarabine evaluate antileukemic efficacy AML , ALL , CML-accelerated blastic phase term complete response ( CR ) rate , response duration , survival ; ( 2 ) analyze relationship cellular uptake retention clofarabine triphosphate ( active metabolite ) , inhibition DNA synthesis , clinical outcome . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Clofarabine</mesh_term>
	<criteria>Patient diagnose AML , ALL , myelodysplastic syndrome ( MDS ) , CML transformation ( include CMLblastic phase CMLaccelerated phase ) . No prior chemo , immuno , radiotherapy 2 week enter study , unless progressive lifethreatening leukemia judge treated physician . Adequate liver function ( bilirubin &lt; /= 2 mg % ) renal function ( creatinine &lt; /= 2 mg % ) . Pregnant lactating female eligible . Zubrod performance status 02 Adequate cardiac status No lifethreatening condition ( e.g . infection ) may cause death within 3 week .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>clinical</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>investigational drug clofarabine</keyword>
	<keyword>AML , ALL , CML-accelerated phase , CML-blastic phase</keyword>
	<keyword>Chronic Myelogenous Leukemia - accelerate phase</keyword>
	<keyword>Chronic Myelogenous Leukemia - blastic phase</keyword>
</DOC>